http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017025936-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04f68c15cdf8d1a4bfe27ccb119a1040
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-225
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
filingDate 2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7469933de052359d6c278f26c997db9
publicationDate 2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017025936-A2
titleOfInvention Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
abstract The present invention relates to selected strains of lactic bacteria for use in the treatment of infections caused by pathogenic bacteria belonging to the species Propionibacterium acnes, in particular for use in the preventive and/or curative treatment of dermatitis in general, seborrheic dermatitis, rosacea, eczema and acne. In addition, the present invention relates to a composition which comprises a mixture comprising or, alternatively, consisting of selected strains of lactic bacteria for use in the treatment of infections caused by pathogenic bacteria belonging to the species Propionibacterium acnes, in particular for use in the preventive and/or curative treatment of dermatitis in general, seborrheic dermatitis, rosacea, eczema and acne. The composition comprising said mixture of selected strains of lactic bacteria is formulated in a pharmaceutical form for oral use (novel food, supplement product or medical device or pharmaceutical composition) in the form of powder, dispersible powder, granulate, packets or stick, solution, spray solution, syrup, tablet, capsule, pill or lozenge; or for topical use (composition for medical device or pharmaceutical composition) in the form of cream, ointment, pomade, gel, hydrogel, dispersion, emulsion or spray to be used as such for skin applications, or for transdermal use even in the form of a band aid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-202000018901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201700068009-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3513799-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018234994-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110891431-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022024027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-201700068000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018234995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020234382-A1
priorityDate 2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9810743-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1995307-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011182861-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014370107-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014065115-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014096641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011029784-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54749604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577477

Total number of triples: 59.